Anti-HCV seroconversion in multitransfused and immunocompromised patients. A long-term longitudinal study

Vox Sang. 1994;67(3):286-90. doi: 10.1111/j.1423-0410.1994.tb01253.x.

Abstract

In a series of 6 multitransfused, immunocompromised patients, the diagnosis of posttransfusion hepatitis C was based upon the analysis of long-term follow-up serum samples. The HCV RNA was detected by a nested PCR assay using primers located in the 5' noncoding region (5'NCR), and anti-HCV antibodies were assayed with third-generation tests. The interval between the first rise in alanine aminotransferase and seroconversion varied from less than 5 months to more than 38 months. Five out of 6 patients seroconverted after 14 months or later. In most cases, the anti-NS3 and anti-NS4 antibodies appeared first. In such patients, the etiology of chronic liver disease may thus be overlooked for 1 or more years, a definitive diagnosis requiring the detection of HCV RNA.

MeSH terms

  • Adult
  • Alanine Transaminase / blood
  • Bone Marrow Transplantation
  • Child
  • Follow-Up Studies
  • Hematologic Diseases / complications
  • Hematologic Diseases / therapy
  • Hepacivirus / isolation & purification
  • Hepatitis Antibodies / blood*
  • Hepatitis C / enzymology
  • Hepatitis C / epidemiology*
  • Hepatitis C / immunology
  • Hepatitis C / transmission*
  • Hepatitis C / virology
  • Hepatitis C Antibodies
  • Humans
  • Immunocompromised Host*
  • Incidence
  • Polymerase Chain Reaction
  • RNA, Viral / blood
  • Transfusion Reaction*
  • Viremia / virology

Substances

  • Hepatitis Antibodies
  • Hepatitis C Antibodies
  • RNA, Viral
  • Alanine Transaminase